William Dai - Founding Managing Partner @ Shangbay Capital

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

William Dai serves as the Founding Managing Partner at ShangBay Capital.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Fluid Biomed	Shangbay Capital	—	Series A - Fluid Biomed	obfuscated obfuscation
obfuscated obfuscation	Avation Medical	Shangbay Capital	Yes	Series C - Avation Medical	obfuscated obfuscation
obfuscated obfuscation	Laplace Interventional	Shangbay Capital	Yes	Series B - Laplace Interventional	obfuscated obfuscation
obfuscated obfuscation	Luminopia	Shangbay Capital	—	Series A - Luminopia	obfuscated obfuscation
obfuscated obfuscation	SetPoint Medical	Shangbay Capital	—	Series C - SetPoint Medical	obfuscated obfuscation
obfuscated obfuscation	Luminopia	Shangbay Capital	Yes	Seed Round - Luminopia	obfuscated obfuscation
obfuscated obfuscation	Laplace Interventional	Shangbay Capital	Yes	Series A - Laplace Interventional	obfuscated obfuscation
obfuscated obfuscation	Fluid Biomed	Shangbay Capital	Yes	Seed Round - Fluid Biomed	obfuscated obfuscation
obfuscated obfuscation	SetPoint Medical	Shangbay Capital	—	Series B - SetPoint Medical	obfuscated obfuscation
obfuscated obfuscation	Aqua Medical	Shangbay Capital	Yes	Series A - Aqua Medical	obfuscated obfuscation

Number of Current Jobs

is the

Founding Managing Partner

Number of Current Board & Advisor Roles

holds

board and advisor roles including

Board of Director

Board Member

, and

Board Member

Hub Name	CB Rank (Hub)
Silicon Valley Companies (Top 10K)	2,609
San Francisco Bay Area Late Stage Venture Investors	21,198
Biotechnology Companies (Top 10K)	714
Palo Alto Late Stage Venture Investors	80,361
Silicon Valley Companies With Less Than $1B in Revenue (Top 10K)	4,962
Silicon Valley Companies With Less Than $10M in Revenue (Top 10K)	7,034
Silicon Valley Companies With Fewer Than 100 Employees (Top 10K)	4,521
Palo Alto Venture Capital Investors	50,593
Palo Alto Investors with Funds Raised in 2021	91,688
Biotechnology Companies With Fewer Than 1000 Employees (Top 10K)	1,249

Number of Events

has participated in

event,

Jan 16, 2025

There is no recent news or activity for this profile.